Beijing, Oct 14: A private Chinese biotechnology company is planning to mass produce a vaccine to contain Ebola virus. Tianjin CanSino Biotechnology Inc has started construction of an industry base to produce the vaccine, developed by a team of biotech experts with the Chinese Academy of Military Medical Sciences, in the Tianjin Economic and Technological Development Area, the company said.